SurModics, Inc. (SRDX) Tops Q2 EPS by 4c

SurModics, Inc. (NASDAQ: SRDX) reported Q2 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $146 million versus the consensus estimate of $14.84 million.

For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Quantinuum Inc (QNT) PT Raised to $95 at Bernstein SocGen Group
• NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark